×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Insulin Signaling in Parkinson's Disease
mechanism
4,072 words
KG: insulin
2026-03-24
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
Insulin Signaling in Parkinson's Disease
⚙
Mechanism Info
Name
Insulin Signaling in Parkinson's Disease
Summary
Page for Insulin Signaling in Parkinson's Disease
Key Genes/Proteins
TUG
,
Insulin receptor
Related Diseases
blood glucose levels
,
glucose storage
Linked Hypotheses
3 hypotheses
Knowledge Graph
Related Hypotheses (30)
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.47
Smartphone-Detected Motor Variability Correction
Score: 0.56
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Retinal Vascular Microcirculation Rescue
Score: 0.54
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.50
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50
Ganglioside Rebalancing Therapy
Score: 0.50
Orexin-Microglia Modulation Therapy
Score: 0.49
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Microglial Purinergic Reprogramming
Score: 0.48
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.48
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Ocular Immune Privilege Extension
Score: 0.47
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Show 25 more
Related Experiments (30)
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.46
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.46
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.46
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.46
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.46
Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.46
Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.46
Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.46
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.46
Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.46
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.46
Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.46
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.46
Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.46
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46
Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.46
DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.46
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.46
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.46
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.46
Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.46
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.46
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.46
Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.46
Cytochrome Therapeutics
clinical · proposed · Score: 0.46
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.46
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.46
Show 25 more
See Also (3)
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates
ACTB Gene
gene · KG edge: activates
ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: inhibits
Knowledge Graph (4 edges)
insulin
regulates
blood glucose levels
insulin
associated_with
glucose storage
insulin
activates
Insulin receptor
insulin
stimulates
TUG